Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

[Lower urinary tract infections: bacterial epidemiology and recommendations].

Bergogne-Bérézin E.

Prog Urol. 2008 Feb;18(1 Suppl FMC):F11-4. Review. French.

PMID:
18773847
2.

The increasing role of Acinetobacter species as nosocomial pathogens.

Bergogne-Bérézin E.

Curr Infect Dis Rep. 2007 Oct;3(5):440-4. doi: 10.1007/s11908-007-1011-2.

PMID:
24395482
3.

[How can we improve the prescription of antibiotics?].

Bergogne-Bérézin E.

Presse Med. 2004 Jul 31;33(13):896-901. Review. French. No abstract available.

PMID:
15387390
4.

[After the "era of antibiotics", the "era of resistance"].

Bergogne-Bérézin E.

Presse Med. 2004 Jul 10;33(12 Pt 1):772-4. French. No abstract available.

PMID:
15343090
5.

Pharmacodynamics of antibiotics in the respiratory tree.

Bergogne-Bérézin E.

Expert Opin Pharmacother. 2004 Jan;5(1):15-23. Review.

PMID:
14680432
6.

Antibiotic tissue concentrations revisited in lungs.

Bergogne-Berezin E.

Crit Care Med. 2003 Aug;31(8):2242-3. No abstract available.

PMID:
12973188
7.

[Pharmacologic innovations, the fluoroquinolone model].

Bergogne-Bérézin E.

Presse Med. 2003 Mar 15;32(10):466-9. French.

PMID:
12733312
8.

[Latest news on fluoroquinolones].

Bergogne-Bérézin E.

Presse Med. 2002 Nov 30;31(38):1805-6. Review. French.

PMID:
12497722
9.

[Anti-infective agents and bacterial resistance, monitor, eradicate or avoid resistance?].

Bergogne-Bérézin E.

Presse Med. 2002 Nov 30;31(38):1779. French. No abstract available.

PMID:
12497715
10.

[Drawbacks and problems of infectiology today].

Bergogne-Bérézin E.

Presse Med. 2002 Oct 5;31(32):1491-2. French. No abstract available.

PMID:
12402752
11.

Controlling acute bacterial maxillary sinusitis.

Bergogne-Bérézin E.

Expert Opin Pharmacother. 2002 Oct;3(10):1471-9. Review.

PMID:
12387693
12.

Clinical role of protein binding of quinolones.

Bergogne-Bérézin E.

Clin Pharmacokinet. 2002;41(10):741-50. Review.

PMID:
12162760
13.

Guidelines on antimicrobial chemotherapy for prevention and treatment of infections in the intensive care unit.

Bergogne-Bérézin E.

J Chemother. 2001 Nov;13 Spec No 1(1):134-49. Review.

PMID:
11936358
14.

[Blood culture update].

Muller-Serieys C, Bergogne-Bérézin E.

Presse Med. 2002 Jan 12;31(1 Pt 1):27-32. Review. French.

PMID:
11826583
15.

[Epidemiology and management of suspected pneumonia in nursing home residents].

Veyssier P, Bergogne-Bérézin E, Gallinari C, Rocca-Serra JP, Benhamou D, Taytard A, Chiarelli P, Boumendil O.

Presse Med. 2001 Dec 1;30(36):1770-6. French.

PMID:
11771202
16.

[Antibacterial antibiotics. Classification, principles and utilization rules].

Bergogne-Bérézin E.

Rev Prat. 1998 May 1;48(9):991-7. French. No abstract available.

PMID:
11767360
17.

The Increasing Role of Acinetobacter Species As Nosocomial Pathogens.

Bergogne-Bérézin E.

Curr Infect Dis Rep. 2001 Oct;3(5):440-444.

PMID:
11559464
18.

[Antibacterial antibiotics. Classification, principles and rules of use].

Bergogne-Bérézin E.

Rev Prat. 2001 Apr 30;51(8):903-9. French. No abstract available.

PMID:
11387695
19.

The suppository form of antibiotic administration: pharmacokinetics and clinical application.

Bergogne-Bérézin E, Bryskier A.

J Antimicrob Chemother. 1999 Feb;43(2):177-85. Review.

PMID:
11252322
20.

[West Nile virus (WNV) encephalitis].

Bergogne-Bérézin E.

Presse Med. 2000 Dec 2;29(37):2046-7. French.

PMID:
11155732
21.
22.

[Resistance and new antibiotic strategies. The other new molecules].

Bergogne-Bérézin E.

Presse Med. 2000 Dec 2;29(37):2028-32. French.

PMID:
11155725
23.

[Resistance and new antibiotic strategies. New antistaphylococcal antibiotics].

Bergogne-Bérézin E.

Presse Med. 2000 Dec 2;29(37):2023-7. Review. French.

PMID:
11155724
24.

Treatment and prevention of antibiotic associated diarrhea.

Bergogne-Bérézin E.

Int J Antimicrob Agents. 2000 Dec;16(4):521-6. Review.

PMID:
11118872
25.

[3rd European Congress of Chemotherapy (Madrid 7-11 May 2000). Resistance of bacteria to antibiotics: an ever increasing problem].

Bergogne-Bérézin E.

Presse Med. 2000 Jul 8-15;29(24):1361-3. French. No abstract available.

PMID:
10938695
26.

[ICAA 1999: news in antibiotic therapy].

Bergogne-Bérézin E.

Presse Med. 1999 Nov 27;28 Suppl 3:25-34. Review. French.

PMID:
10605466
27.

Current guidelines for the treatment and prevention of nosocomial infections.

Bergogne-Bérézin E.

Drugs. 1999 Jul;58(1):51-67. Review.

PMID:
10439929
28.

[New developments in pharmacology of antibiotics].

Bergogne-Bérézin E.

Presse Med. 1998 Dec;27 Suppl 5:51-4. French.

PMID:
9879338
29.

[New development in clinical pharmacology of anti-infective agents].

Bergogne-Bérézin E.

Presse Med. 1998 Dec;27 Suppl 5:34-41. French.

PMID:
9879335
30.

[Forum on bacterial resistance].

Bergogne-Bérézin E, Courvalin P, Gehanno P, Demaresy J, Perronne C, Ducluzeau R.

Presse Med. 1998 Nov 14;27(35):1796-800. French.

PMID:
9850699
31.

Clinical and bacteriologic epidemiology of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit.

Decré D, Gachot B, Lucet JC, Arlet G, Bergogne-Bérézin E, Régnier B.

Clin Infect Dis. 1998 Oct;27(4):834-44.

PMID:
9798042
32.

Pharmacokinetics of cefuroxime in healthy volunteers: an update.

Massias L, Muller-Serieys C, Farinotti R, Bergogne-Bérézin E.

J Antimicrob Chemother. 1998 Sep;42(3):408-10. No abstract available.

PMID:
9786491
33.

Dirithromycin concentrations in bronchial mucosa and secretions.

Leroyer C, Muller-Serieys C, Quiot J, Benhamou D, Clavier J, Bergogne-Bérézin E.

Respiration. 1998;65(5):381-5.

PMID:
9782221
34.

[The birth of hospital bacteriology].

Bergogne-Bérézin E.

Rev Prat. 1998 Jun 15;48(12):1284-8. French. No abstract available.

PMID:
9781185
35.

[Prevention of infection at the extreme ages of life].

Bergogne-Bérézin E.

Presse Med. 1998 Jun;27 Suppl 3:16-9. French. No abstract available.

PMID:
9767767
36.

[Antibiotic pressure and bacterial resistance in the hospital].

Bergogne-Bérézin E.

Presse Med. 1998 Jun;27 Suppl 3:5-14. Review. French. No abstract available.

PMID:
9767766
37.

[Prevention of resistance to antibiotics. A complex problem].

Bergogne-Bérézin E.

Presse Med. 1998 Jun;27 Suppl 3:3. French. No abstract available.

PMID:
9767765
38.

[Ceftriaxone: pharmacokinetics, pharmacodynamics. Application in the treatment of acute otitis media in children].

Bergogne-Bérézin E.

Presse Med. 1997 Nov 29;26(37):1827-34. Review. French. No abstract available.

PMID:
9569905
39.

[Infectious diseases: almost 60 years of antibiotic use].

Bergogne-Bérézin E.

Presse Med. 1997 Nov 29;26(37):1766-7. French. No abstract available.

PMID:
9569896
40.
41.

Who or what is the source of antibiotic resistance?

Bergogne-Bérézin E.

J Med Microbiol. 1997 Jun;46(6):461-4. No abstract available.

PMID:
9379476
42.
43.

[Fluoroquinolones. Pharmacokinetic properties and new pharmacodynamic concepts].

Bergogne-Bérézin E.

Presse Med. 1997 Apr 12;26(12):577-82. Review. French. No abstract available.

PMID:
9161437
44.

[New pharmacological approaches of macrolides. Example of roxithromycin].

Bergogne-Bérézin E.

Presse Med. 1997 Mar;26 Suppl 2:4-10. Review. French.

PMID:
9113046
45.

Treatment of Acinetobacter infections.

Bergogne-Bérézin E.

Expert Opin Investig Drugs. 1997 Feb;6(2):119-27.

PMID:
15989595
46.

[New pharmacologic approaches to macrolides: example of roxithromycin].

Bergogne-Bérézin E.

Presse Med. 1996 Dec 14;25(39):1982-8. Review. French.

PMID:
9033622
47.

Characterisation of DNA gyrase and measurement of drug accumulation in clinical isolates of Acinetobacter baumannii resistant to fluoroquinolones.

Moreau NJ, Houot S, Joly-Guillou ML, Bergogne-Bérézin E.

J Antimicrob Chemother. 1996 Dec;38(6):1079-83.

PMID:
9023657
48.

European multicentre evaluation of a commercial system for identification of methicillin-resistant Staphylococcus aureus.

Zambardi G, Fleurette J, Schito GC, Auckenthaler R, Bergogne-Berezin E, Hone R, King A, Lenz W, Lohner C, Makristhatis A, Marco F, Müller-Serieys C, Nonhoff C, Phillips I, Rohner P, Rotter M, Schaal KP, Struelens M, Viebahn A.

Eur J Clin Microbiol Infect Dis. 1996 Sep;15(9):747-9.

PMID:
8922577
49.

Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Bergogne-Bérézin E, Towner KJ.

Clin Microbiol Rev. 1996 Apr;9(2):148-65. Review. No abstract available.

50.

[Therapeutic applications of tissue pharmacokinetics of antibiotics].

Bergogne-Bérézin E.

Presse Med. 1996 Mar 2-9;25(8):408-10, 412-4, 416-8. Review. French.

PMID:
8685189

Supplemental Content

Loading ...
Support Center